INTESTINAL DYSBIOSIS AND ANTIBIOTIC-ASSOCIATED DIARRHEA IN A HOSPITAL SETTING: PREVENTION AND CORRECTION

DOI: https://doi.org/10.29296/25877305-2019-12-21
Download full text PDF
Issue: 
12
Year: 
2019

Professor Yu. Uspensky , MD; N. Baryshnikova , Candidate of Medical Sciences Saint Petersburg State Pediatric Medical University Acad. I.P. Pavlov First Saint Petersburg State Medical University Institute of Experimental Medicine, Saint Petersburg

The combined use of antibiotics and metabiotics substantially increases the efficiency and safety of therapy. The use of metabiotics can create a controlled intestinal microbiocenosis, since the metabolic, signaling, transport and other functions of representatives of the endogenous microbiota are of more importance than the quantitative content of microorganisms of certain species in the biotope.
Keywords: 
herapy
antibiotic therapy
undesirable sequels
intestinal dysbiosis
metabiotics

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Belousova L.N., Baryshnikova N.V. Antibiotiki i probiotiki: obespechenie effektivnosti i bezopasnosti // Vrach. – 2012; 1: 26–8 [Baryshnikova N., Belousova L. Antibiotics and probiotics: provision of efficacy and safety // Vrach. – 2012; 1: 26–8 (in Russ.)].
  2. Tkachenko E.I., Uspenskij Ju.P. Pitanie, mikrobiotsenoz i intellekt cheloveka / SPb: SpetsLit, 2006; 590 s. [Tkachenko E.I., Uspenskii Yu.P. Pitanie, mikrobiotsenoz i intellekt cheloveka / SPb: SpetsLit, 2006; 590 s. (in Russ.)].
  3. Uspenskij Ju.P., Fominyh Ju.A. Antibiotik-assotsiirovannaja diareja: aktual'nost' problemy, profilaktika i terapija // Arhiv vnutrennej meditsiny. – 2013; 2 (10): 46–53 [Uspenskii Yu.P., Fominykh Yu.A. Antibiotik-assotsiirovannaya diareya: aktual’nost’ problemy, profilaktika i terapiya // The Russian Archives of Internal Medicine. – 2013; 2 (10): 46–53 (in Russ.)]. https://doi.org/10.20514/2226-6704-2013-0-2-46-53.
  4. Disbioz kishechnika. Rukovodstvo po diagnostike i lecheniju. 3-e izd., ispr. i dop. Pod red. A.N. Suvorova, E.I. Tkachenko, Ju.P. Uspenskogo / SPb: InformMed, 2013; 270 s. [Disbioz kishechnika. Rukovodstvo po diagnostike i lecheniyu. 3-e izd., isp. i dop. Pod red. A.N. Suvorova, E.I. Tkachenko, Yu.P. Uspenskogo / SPb: InformMed, 2013; 270 s. (in Russ.)].
  5. Andreeva I.V. Dokazatel'noe obosnovanie primenenija probiotikov dlja lechenija i profilaktiki zabolevanij ZhKT [elektronnyj resurs]. [Andreeva I.V. Dokazatel’noe obosnovanie primeneniya probiotikov dlya lecheniya i profilaktiki zabolevanii ZhKT [elektronnyi resurs] (in Russ.)]. URL: http://bono-esse.ru/blizzard/RPP/M/GKT/probiotik.html (data obraschenija 15.12.2019).
  6. Strachunskij L.S., Belousov Ju.B., Kozlov S.N. Prakticheskoe rukovodstvo po antiinfektsionnoj himioterapii / M., 2002; 384 s. [Strachunskii L.S., Belousov Yu.B., Kozlov S.N. Prakticheskoe rukovodstvo po antiinfektsionnoi khimioterapii / M., 2002; 384 s. (in Russ.)].
  7. Shenderov B.A. Meditsinskaja mikrobnaja ekologija i funktsional'noe pitanie. T. 1 / M.: Grant', 1988; s. 246–85 [Shenderov B.A. Meditsinskaya mikrobnaya ekologiya i funktsional’noe pitanie. T. 1 / M.: Grant, 1988; s. 246–85 (in Russ.)].
  8. Baryshnikova N.V. Korrektsija narushenij mikrobiotsenoza kishechnika u bol'nyh hronicheskim gastroduodenitom, assotsiirovannym s Helicobacter pylori // Eksperim. i klin. gastroenterol. – 2008; 8: 92–9 [Baryshnikova N.V. Korrektsiya narushenii mikrobiotsenoza kishechnika u bol’nykh khronicheskim gastroduodenitom, assotsiirovannym s Helicobacter pylori // Eksperim. i klin. gastroenterol. – 2008; 8: 92–9 (in Russ.)].
  9. Havkin A.I., Zhihareva N.S. Antibiotik-assotsiirovannyj disbakterioz // Spravochnik poliklinicheskogo vracha. – 2006; 4 (8): 59–62 [Khavkin A.I., Zhikhareva N.S. Antibiotik-assotsiirovannyi disbakterioz // Spravochnik poliklinicheskogo vracha. – 2006; 4 (8): 59–62 (in Russ.)].
  10. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection // Ther. Adv. Gastroenterol. – 2011; 4 (3): 185–97. DOI: 10.1177/1756283X11399115
  11. Shul'pekova Ju.O. Antibiotikoassotsiirovannaja diareja // RMZh. – 2007; 15 (6): 1–6 [Shul’pekova Yu.O. Antibiotikoassotsiirovannaya diareya // RMZh. – 2007; 15 (6): 1–6 (in Russ.)].
  12. Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) // Clin. Microbiol. Infect. – 2009; 15: 1067–79. DOI: 10.1111/j.1469-0691.2009.03099.x.
  13. Stuart H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) // Infect. Control. Hosp. Epidemiol. – 2010; 31 (5): 431–55.
  14. Korneeva O.N., Ivashkin V.T. Antibiotikoassotsiirovannyj kolit: patomorfologija, klinika, lechenie // RZhGGK. – 2007; 3: 65–70 [Korneyeva O.N., Ivashkin V.T. Antibiotic-associated colitis: patho-morphology, clinical presentation, treatment // RZhGGK [Russian Journal of Gastroenterology, Hepatology, Coloproctology]. – 2007; 3: 65–70 (in Russ.)].
  15. Avadhani A., Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults-a metaanalysis // J. Am. Acad. Nurse. Pract. – 2011; 23 (6): 269–74. DOI: 10.1111/j.1745-7599.2011.00617.x.
  16. Videlock E., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhea // Aliment. Pharmacol. Ther. – 2012; 35 (12): 1355–69. DOI: 10.1111/j.1365-2036.2012.05104.x.
  17. Kruglyj stol «Metabiotiki: novaja ideja ili estestvennoe razvitie probioticheskoj kontseptsii» // RMZh «Meditsinskoe obozrenie». – 2017; 2: 106–10 [Kruglyi stol «Metabiotiki: novaya ideya ili estestvennoe razvitie probioticheskoi kontseptsii» // RMZh «Meditsinskoe obozrenie». – 2017; 2: 106–10 (in Russ.)]. URL: https://www.rmj.ru/articles/gastroenterologiya/Kruglyy_stol_Metabiotiki_novaya_ideya_ili_estestvennoe_razvitie_probioticheskoy_koncepcii/#ixzz67befLJov (data obraschenija 09.12.2019)
  18. Aas J., Gessert C., Bakken J. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube // Clin. Infect. Dis. – 2003; 36: 580–5. DOI: 10.1086/367657.
  19. Babcock G., Broering T., Hernandez H. et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters // Infect. Immun. – 2006; 74: 6339–47. DOI: 10.1128/IAI.00982-06.